We are live on
!
Find out more
CC
Cadinha & Co Portfolio holdings
AUM
$675M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
-12.75%
1 Year Est. Return
+30.64%
3 Year Est. Return
+122.92%
5 Year Est. Return
+204.29%
10 Year Est. Return
+776.02%
AUM
$447M
AUM Growth
-$247M
(-36%)
Cap. Flow
-$159M
Cap. Flow
% of AUM
-35.61%
Top 10 Holdings %
Top 10 Hldgs %
60.94%
Holding
112
New
5
Increased
16
Reduced
52
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$37.9M |
| 2 |
B
Barrick Mining
B
|
+$16.8M |
| 3 |
Procter & Gamble
PG
|
+$15.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$15M |
| 5 |
Shell
SHEL
|
+$14.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$38.3M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$35M |
| 3 |
Home Depot
HD
|
+$21.2M |
| 4 |
CVS Health
CVS
|
+$20.3M |
| 5 |
Intel
INTC
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.75% |
| 2 | Miscellaneous | 23.38% |
| 3 | Technology | 12.74% |
| 4 | Consumer Staples | 10.26% |
| 5 | Materials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$46.8B
| $67.4M | 15.06% |
586,742
+321,476
| +121% | +$37.9M |
|
2
Johnson & Johnson
JNJ
$646B
| $27.3M | 6.11% |
154,044
-2,769
| -2% | -$493K |
|
3
Merck
MRK
$366B
| $26.7M | 5.97% |
293,166
+65,135
| +29% | +$5.77M |
|
4
Costco
COST
$419B
| $26.2M | 5.86% |
54,664
-830
| -1% | -$421K |
|
5
Berkshire Hathaway Class B
BRK.B
$1.08T
| $25.5M | 5.71% |
93,518
-338
| -0.4% | -$106K |
|
6
Chevron
CVX
$396B
| $25.3M | 5.65% |
174,688
-2,045
| -1% | -$338K |
|
7
Apple
AAPL
$4.67T
| $21.6M | 4.82% |
157,793
-3,005
| -2% | -$455K |
|
8
Intuitive Surgical
ISRG
$132B
| $18.6M | 4.15% |
92,472
+26,084
| +39% | +$6.12M |
|
9
Microsoft
MSFT
$3.81T
| $17.4M | 3.89% |
67,763
-17,430
| -20% | -$4.73M |
|
|
10
Procter & Gamble
PG
$334B
| $16.6M | 3.72% |
115,753
+104,635
| +941% | +$15.7M |
|
|
11
Bristol-Myers Squibb
BMY
$136B
| $15.1M | 3.38% |
+196,680
| New | +$15M |
|
12
Freeport-McMoran
FCX
$110B
| $15.1M | 3.38% |
516,769
-305,352
| -37% | -$12.2M |
|
|
13
Shell
SHEL
$250B
| $14.5M | 3.25% |
278,157
+265,730
| +2,138% | +$14.9M |
|
|
B
14
Barrick Mining
B
$75.1B
| $14M | 3.12% |
789,135
+772,782
| +4,726% | +$16.8M |
|
|
15
iShares Core S&P 500 ETF
IVV
$898B
| $13.8M | 3.09% |
36,492
-93,002
| -72% | -$38.3M |
|
|
FISV
16
Fiserv Inc
FISV
$28.3B
| $13.6M | 3.03% |
+152,610
| New | +$14.8M |
|
17
BHP
BHP
$242B
| $12.2M | 2.72% |
216,620
-78,869
| -27% | -$4.9M |
|
18
Eli Lilly
LLY
$1.05T
| $7.63M | 1.71% |
23,540
-45,056
| -66% | -$13.5M |
|
19
Union Pacific
UNP
$183B
| $3.33M | 0.74% |
15,625
-212
| -1% | -$48.2K |
|
20
State Street SPDR S&P 500 ETF Trust
SPY
$825B
| $2.34M | 0.52% |
6,202
| – | – |
|
21
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
| $2.3M | 0.51% |
20,878
-1,174
| -5% | -$129K |
|
22
Danaher
DHR
$152B
| $2.09M | 0.47% |
9,300
-1,536
| -14% | -$354K |
|
23
Alphabet (Google) Class A
GOOGL
$4.24T
| $2.08M | 0.47% |
19,100
-109,300
| -85% | -$12.9M |
|
24
iShares US Treasury Bond ETF
GOVT
$44.3B
| $1.97M | 0.44% |
82,275
-241,473
| -75% | -$5.81M |
|
25
iShares Gold Trust
IAU
$66.1B
| $1.94M | 0.43% |
56,462
-3,474
| -6% | -$124K |
|
Similar funds
TW
BA
CCA
EGWAG
W
OFS
VPP
DAM
Cadinha & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Cadinha & Co held 112 positions worth $447M, down 36% from $694M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Cadinha & Co withdrew a net $159M in Q2 2022, closing 16 positions and reducing 52 holdings. Its most notable exit was Wheaton Precious Metals, an estimated $18.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 18% a quarter earlier, followed by Miscellaneous and Technology.
Against the trend, Cadinha & Co opened a new position in Bristol-Myers Squibb worth $15.1M.
- Cadinha & Co's largest Q2 2022 buy was Bristol-Myers Squibb: 196,680 shares worth $15.1M.
- Cadinha & Co added most to iShares 20+ Year Treasury Bond ETF in Q2 2022, an estimated $37.9M increase.
- Cadinha & Co's biggest Q2 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $38.3M.
- Cadinha & Co fully exited Wheaton Precious Metals in Q2 2022, selling an estimated $18.8M.
- Cadinha & Co's ten largest holdings make up 61% of its $447M portfolio in Q2 2022.
- Cadinha & Co opened 5 new positions and closed 16 in Q2 2022.
- Cadinha & Co's portfolio value fell 36% quarter-over-quarter to $447M.
Based on Cadinha & Co's 13F filing for Q2 2022, filed 5 Aug 2022.